The interim final rule to permit electronic prescriptions for controlled substances requires an indication that a prescription has been digitally signed, but it will take time to modify the e-prescribing transaction to add the new field.

Until then, alternative interim solutions exist and should be used, according to Emdeon Business Services, a vendor of claims clearinghouse and revenue cycle management software and services. The Nashville, Tenn.-based company recently submitted comments on the rule to the Drug Enforcement Administration within the Department of Justice.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access